Financials
Financial year 2025
Eelen Clinical Consulting from Lier, company number BE0843562181, closed financial year 2025 with a result of € -568 after tax. For that financial year Eelen Clinical Consulting recorded a gross margin of € 51,495 and equity of € 321,112. Compared with financial year 2024, the result moved from € 12,717 to € -568. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 22, 2025.
€ 321,112
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -568
▼ still € 12,717 profit in 2024
Profit after tax over the fiscal year.
€ 62,505
▼ 9% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 301,112.
People and assets in 2025
€ 29,729
▼ 19% vs 2024
Of which on lease € 22,686.
Debts at end 2025
€ 123,145
▼ 15% vs 2024
€ 22,144 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 18,180
▲ € 17,885 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,641
▲ 92% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 97,673 | € 78,437 | € 57,611 | € 51,495 | ▼ 11% |
| Profit after taxes | € 50,590 | € 30,658 | € 12,717 | € -568 | ▼ € 13,284 |
| Equity | € 278,305 | € 308,963 | € 321,680 | € 321,112 | |
| Total debts | € 171,238 | € 190,599 | € 150,049 | € 145,966 | ▼ 3% |
| Cash | € 101,774 | € 94,496 | € 69,058 | € 62,505 | ▼ 9% |
| Land & buildings | € 141,249 | € 126,786 | € 112,323 | € 97,860 | ▼ 13% |
| Retained profit | € 258,305 | € 288,963 | € 301,680 | € 301,112 | |
| Bank debt | € 137,798 | € 165,500 | € 144,642 | € 123,145 | ▼ 15% |
| Balance sheet total | € 449,544 | € 499,562 | € 471,729 | € 467,078 | ▼ 1% |
Key figures of Eelen Clinical Consulting, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Eelen Clinical Consulting?
What happened at Eelen Clinical Consulting in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 568 (▼ € 13,284 vs 2024). Source: NBB ↗
- New establishment in Lier. KBO
- Jan Eelen became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 50,590 profit in 2022 to € 568 loss in 2025.
Paid € 59,900 in corporate taxes since 2022.
Best year ever: 2022, with € 50,590 profit.
Management
Behind Eelen Clinical Consulting is Jan Eelen. Jan Eelen is also behind INVESTRIUM, Xper Research and Lorentis.
Directors
According to the 2025 annual accounts
since 2012
Establishments
Establishment units
Physical locations of this company
Posthoornstraat 14
2500 Lier
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0843.562.181
- VAT number
- BE 0843.562.181
- Registered office
- Posthoornstraat 14, 2500 Lier
- Names & denominations
- Eelen Clinical Consulting
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 February 2012
- Peppol
- Active · Active since 18 Nov 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Speur- en ontwikkelingswerk op biotechnologisch gebied
Activiteiten van holdings
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Activiteiten van medische laboratoria
+3